Archer-Daniels-Midland Co (ADM) Stock Analysis and Metrics

Archer-Daniels-Midland

NYSE: ADM

$85.91 ▼ -0.44 (-0.51%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap41.79 Bn

P/E38.55

P/S0.52

Div. Yield0.00

ROIC (Qtr)0.00

Total Debt (Qtr)8.22 Bn

Revenue Growth (1y) (Qtr)1.56

Add ratio to table…

About

Archer-Daniels-Midland Company, commonly known as ADM, is a global leader in agricultural processing and supply chain management, connecting farmers with markets to deliver food, feed, fuel, and industrial products. Operating at the intersection of agriculture and nutrition, ADM sources, transports, and processes crops such as soybeans, corn, and wheat into a diverse portfolio of ingredients and solutions. The company plays a pivotal role in the global food system, enabling food security by transforming raw commodities into value-added products for human and animal consumption, as well as industrial applications. ADM also drives innovation in health and wellness, biofuels, and sustainable agricultural practices, positioning itself as a key enabler of the bioeconomy.

ADM generates revenue through the procurement, processing, and sale of agricultural commodities and derived products. Its primary revenue streams include the sale of oilseeds, protein meals, vegetable oils, corn-based sweeteners, starches, ethanol, and specialty nutrition ingredients. The company serves a broad customer base, including food and beverage manufacturers, livestock producers, biofuel producers, and industrial users. Revenue is also derived from structured trade finance activities, logistics services, and equity investments in joint ventures and affiliates that expand its market reach and product offerings.

The company operates through the following segments.

• Ag Services and Oilseeds: This segment focuses on the origination, merchandising, transportation, and storage of agricultural commodities, including soybeans, soft seeds, and grains. It processes oilseeds into vegetable oils and protein meals for food, feed, and industrial applications, such as biodiesel and renewable diesel. The segment also supplies peanuts, peanut-derived ingredients, and cotton cellulose pulp, while managing a global logistics network that supports trade flows and customer supply chains. ADM holds equity interests in entities like Wilmar International Limited, a leading agribusiness group, and engages in structured trade finance to optimize its global operations.

• Carbohydrate Solutions: This segment converts corn and wheat into sweeteners, starches, syrups, glucose, and ethanol through wet and dry milling processes. Products are used in food and beverage applications, as well as animal feed ingredients like distillers’ grains and corn gluten meal. The segment also produces citric acid and advances carbon capture and sequestration initiatives to support lower-carbon operations and bio-based alternatives to fossil-derived materials. Equity investments in entities such as Hungrana Ltd and Almidones Mexicanos further enhance its production and market capabilities.

• Nutrition: This segment develops and manufactures specialty ingredients and solutions for human and animal nutrition, including plant-based proteins, flavors, colors, probiotics, enzymes, and botanical extracts. It serves food and beverage manufacturers, nutritional supplement producers, livestock and aquaculture feed providers, and pet food manufacturers. The segment also processes edible beans and produces formula feeds and animal health products, leveraging equity investments in companies like ADM Matsutani LLC to expand its innovation and market presence.

ADM holds a dominant position in the global agricultural processing industry, competing on price, quality, supply chain efficiency, and innovation. Its key competitors include Cargill, Bunge, Louis Dreyfus Company, and Ingredion, among others. ADM’s competitive advantages stem from its integrated global supply chain, which spans origination, logistics, and processing, enabling it to manage price volatility and ensure reliable product delivery. The company’s focus on sustainability, including regenerative agriculture and carbon capture initiatives, further differentiates it in an industry increasingly prioritizing environmental stewardship. ADM’s research and development capabilities, with annual investments exceeding $240 million, allow it to innovate in plant-based proteins, biofuels, and health-focused ingredients, reinforcing its leadership in the bioeconomy.

The company’s customer base is diverse and global, encompassing food and beverage manufacturers, livestock and aquaculture producers, biofuel refiners, and industrial users. ADM serves major consumer brands, private label manufacturers, and specialty ingredient buyers, though no single customer accounts for a material portion of its revenue. Its products reach end markets through direct sales, co-manufacturers, and distributors, supported by a comprehensive transportation network that includes trucks, railcars, barges, and ocean vessels. The company’s ability to source raw materials from thousands of farmers and suppliers worldwide ensures a resilient and flexible supply chain.

Investment Thesis

▲ Bull case

ADM's strategic investment in growth platforms such as precision fermentation, biosolutions, and decarbonization is beginning to yield tangible commercial results that were not fully emphasized during the earnings call but are critical to long-term value creation. The company reported progress on a scalable animal-free protein for pet food in animal nutrition and advanced development of a novel enzyme with broad functionality in human nutrition during Q1 2026, both leveraging precision fermentation technology. These initiatives are not speculative; they are already moving beyond pilot stages into early commercialization, supported by existing infrastructure and partnerships. The biosolutions platform, exemplified by the starch-based component for fabric softeners recognized with Henkel’s innovation award, demonstrates ADM’s ability to extract higher value from existing commodity streams by entering adjacent industrial markets with durable demand. Furthermore, the company’s decarbonization efforts—highlighted by sequestering 300,000 metric tonnes of CO2 in Q1 alone—position it to capitalize on rising demand for low-carbon inputs across sectors such as sustainable aviation fuel and renewable natural gas, particularly as 45Z tax credits begin to materialize. These platforms are not being treated as core contributors in current guidance but represent a structural shift toward higher-margin, innovation-driven revenue that could significantly outperform legacy segments over time, especially as traditional commodity margins face cyclical pressure.
The underappreciated strength in ADM’s Nutrition segment, particularly the recovery of the Decatur East plant and momentum in natural flavors, is being driven by structural shifts in consumer demand that go beyond temporary tailwinds. Human nutrition revenue grew 3% year-over-year while operating profit surged 39%, indicating meaningful operating leverage from pricing power, product mix improvement, and operational efficiency. Management attributed this to flavor sales and the return of Decatur East to full operations, but did not fully elaborate on how the plant’s recovery is enabling a renaissance in specialty ingredient production that commands premium pricing in clean-label markets. The facility’s return is not merely a return to prior capacity but represents a strategic repositioning toward high-value, natural ingredients that align with global trends away from artificial additives. Additionally, the company’s expansion in natural colors and flavors in North America is capturing share from competitors still reliant on synthetic alternatives, creating a durable competitive advantage. This trend is reinforced by ongoing innovation in immune support, stress, mood, and sleep solutions within functional health, suggesting a broader platform shift rather than a cyclical rebound. As a result, the Nutrition segment is evolving into a higher-margin, innovation-led growth engine that could sustain double-digit operating profit expansion even if commodity markets weaken.
ADM’s capital allocation discipline and progress on its $500 million to $750 million cost savings initiative—already yielding benefits in Q1 through reduced unplanned downtime and increased throughput—are creating a sustainable foundation for margin expansion that is not fully reflected in current guidance. The company highlighted progress in increasing throughput and decreasing unplanned downtime across its production footprint during Q1, achieving the best overall global site crush production on record. These operational gains are being driven by targeted investments in automation, AI in workflows, and supply chain optimization, which reduce manual touch points and cycle times. While management framed these as cost-saving efforts, they are simultaneously increasing asset utilization and throughput without proportional increases in fixed costs, thereby improving returns on existing capital. The fact that these improvements were achieved despite a challenging macro environment suggests they are structural and scalable. Furthermore, the company’s reaffirmed commitment to returning value via dividends—now at 377 consecutive quarters—combined with its openness to future buybacks as cash flow improves, signals confidence in sustained free cash flow generation. This financial discipline, combined with operational efficiency gains, could allow ADM to exceed its current EPS guidance range of $4.15 to $4.70 if the cost savings initiative delivers at the higher end of its target and growth platforms begin to contribute meaningfully to earnings.

ADM's strategic investment in growth platforms such as precision fermentation, biosolutions, and decarbonization is beginning to yield tangible commercial results that were not fully emphasized during the earnings call but are critical to long-term value creation. The company reported progress on a scalable animal-free protein for pet food in animal nutrition and advanced development of a novel enzyme with broad functionality in human nutrition during Q1 2026, both leveraging precision fermentation technology. These initiatives are not speculative; they are already moving beyond pilot stages into early commercialization, supported by existing infrastructure and partnerships. The biosolutions platform, exemplified by the starch-based component for fabric softeners recognized with Henkel’s innovation award, demonstrates ADM’s ability to extract higher value from existing commodity streams by entering adjacent industrial markets with durable demand. Furthermore, the company’s decarbonization efforts—highlighted by sequestering 300,000 metric tonnes of CO2 in Q1 alone—position it to capitalize on rising demand for low-carbon inputs across sectors such as sustainable aviation fuel and renewable natural gas, particularly as 45Z tax credits begin to materialize. These platforms are not being treated as core contributors in current guidance but represent a structural shift toward higher-margin, innovation-driven revenue that could significantly outperform legacy segments over time, especially as traditional commodity margins face cyclical pressure.
The underappreciated strength in ADM’s Nutrition segment, particularly the recovery of the Decatur East plant and momentum in natural flavors, is being driven by structural shifts in consumer demand that go beyond temporary tailwinds. Human nutrition revenue grew 3% year-over-year while operating profit surged 39%, indicating meaningful operating leverage from pricing power, product mix improvement, and operational efficiency. Management attributed this to flavor sales and the return of Decatur East to full operations, but did not fully elaborate on how the plant’s recovery is enabling a renaissance in specialty ingredient production that commands premium pricing in clean-label markets. The facility’s return is not merely a return to prior capacity but represents a strategic repositioning toward high-value, natural ingredients that align with global trends away from artificial additives. Additionally, the company’s expansion in natural colors and flavors in North America is capturing share from competitors still reliant on synthetic alternatives, creating a durable competitive advantage. This trend is reinforced by ongoing innovation in immune support, stress, mood, and sleep solutions within functional health, suggesting a broader platform shift rather than a cyclical rebound. As a result, the Nutrition segment is evolving into a higher-margin, innovation-led growth engine that could sustain double-digit operating profit expansion even if commodity markets weaken.
ADM’s capital allocation discipline and progress on its $500 million to $750 million cost savings initiative—already yielding benefits in Q1 through reduced unplanned downtime and increased throughput—are creating a sustainable foundation for margin expansion that is not fully reflected in current guidance. The company highlighted progress in increasing throughput and decreasing unplanned downtime across its production footprint during Q1, achieving the best overall global site crush production on record. These operational gains are being driven by targeted investments in automation, AI in workflows, and supply chain optimization, which reduce manual touch points and cycle times. While management framed these as cost-saving efforts, they are simultaneously increasing asset utilization and throughput without proportional increases in fixed costs, thereby improving returns on existing capital. The fact that these improvements were achieved despite a challenging macro environment suggests they are structural and scalable. Furthermore, the company’s reaffirmed commitment to returning value via dividends—now at 377 consecutive quarters—combined with its openness to future buybacks as cash flow improves, signals confidence in sustained free cash flow generation. This financial discipline, combined with operational efficiency gains, could allow ADM to exceed its current EPS guidance range of $4.15 to $4.70 if the cost savings initiative delivers at the higher end of its target and growth platforms begin to contribute meaningfully to earnings.

▼ Bear case

ADM’s reported strength in Ag Services and Oilseeds is heavily influenced by transient market distortions—specifically, negative mark-to-market and timing impacts—that are masking underlying weakness in core operations and creating a misleading impression of strength. In Q1 2026, the segment reported $273 million in operating profit, down 34% year-over-year, but this figure includes approximately $275 million in net negative mark-to-market and timing impacts, of which 70% stemmed from the crushing subsegment. Management acknowledged that the majority of this impact is expected to reverse in Q2 and the second half of 2026, yet they framed the current environment as "constructive" due to rising commodity prices. This creates a risk that investors are misinterpreting accounting volatility as fundamental improvement. The crushing subsegment posted an operating loss of $79 million despite a 2% increase in oilseed tonnage, indicating that higher volumes are not translating to profitability due to hedging inefficiencies or margin compression in physical operations. Furthermore, the reliance on reversing accounting effects to drive future earnings growth introduces significant volatility and unpredictability into forward-looking estimates, especially if commodity prices stabilize or decline. The company’s guidance assumes continued strength in ethanol and a normalization of Chinese soybean purchases, but offers no hedge against the possibility that these tailwinds fade, leaving the core agribusiness exposed to cyclical downturns without sufficient structural improvement in profitability.
The Carbohydrate Solutions segment’s apparent strength, particularly in ethanol, is vulnerable to policy-dependent tailwinds that may not be durable and is being offset by persistent structural decline in starches and sweeteners—a business that management acknowledged is under secular pressure. While ethanol margins strengthened due to RVO clarity and 45Z expectations, the segment’s gains are being driven largely by external policy support rather than inherent operational superiority. Management conceded that starches and sweeteners volumes and margins continue to face pressure from similar trends seen in 2025, with only an 11% increase in operating profit in the subsegment despite broader segment growth of 48%. This indicates that the ethanol-driven upside is not translating into broad-based strength across the carbohydrate portfolio. More concerning is the lack of a clear, scalable path to offset the decline in traditional sweeteners and starches through biosolutions or industrial applications—efforts in areas like personal care or fabric softeners remain nascent and are explicitly described as smaller markets requiring more effort to develop. The company’s strategy of "fighting for the grind" through diversification has yet to demonstrate material revenue contribution at scale, leaving the segment exposed to continued erosion in its core food-facing businesses. If policy support for ethanol wavers or if industrial applications fail to scale, the Carbohydrate Solutions segment could quickly revert to low or negative growth, undermining the narrative of a broad-based recovery.
ADM’s nutrition business, while showing improved profitability, remains exposed to margin pressure from input costs, foreign exchange volatility, and the limited scalability of premium product lines, casting doubt on the sustainability of its recent outperformance. Human nutrition operating profit rose 39% year-over-year, but this was bolstered by foreign exchange gains and the recovery of the Decatur East plant—a facility whose return to full operations is described as ongoing, not yet complete, with management acknowledging they have not recovered their full prior market position. The reliance on facility recovery and FX gains introduces non-recurring elements into the performance beat, suggesting that core organic growth in human nutrition may be more modest than the headline numbers indicate. Furthermore, the company’s shift toward higher-margin product lines in animal nutrition, while beneficial, is constrained by the need to overcome customer inertia and the relatively small size of specialty markets compared to commodity feed. Management cited ongoing cost optimization and portfolio actions as drivers, but these are incremental and may not be sufficient to offset long-term pressure from private label competition and declining demand for traditional feed additives. The segment’s growth is also vulnerable to fluctuations in input costs such as dairy, cocoa, and specialty grains, which are not fully hedged and could compress margins if inflation persists. Without clear evidence of scalable, proprietary innovation beyond flavors and isolated enzyme projects, the nutrition segment’s current momentum may reflect a temporary cyclical bounce rather than a structural transformation.

ADM’s reported strength in Ag Services and Oilseeds is heavily influenced by transient market distortions—specifically, negative mark-to-market and timing impacts—that are masking underlying weakness in core operations and creating a misleading impression of strength. In Q1 2026, the segment reported $273 million in operating profit, down 34% year-over-year, but this figure includes approximately $275 million in net negative mark-to-market and timing impacts, of which 70% stemmed from the crushing subsegment. Management acknowledged that the majority of this impact is expected to reverse in Q2 and the second half of 2026, yet they framed the current environment as "constructive" due to rising commodity prices. This creates a risk that investors are misinterpreting accounting volatility as fundamental improvement. The crushing subsegment posted an operating loss of $79 million despite a 2% increase in oilseed tonnage, indicating that higher volumes are not translating to profitability due to hedging inefficiencies or margin compression in physical operations. Furthermore, the reliance on reversing accounting effects to drive future earnings growth introduces significant volatility and unpredictability into forward-looking estimates, especially if commodity prices stabilize or decline. The company’s guidance assumes continued strength in ethanol and a normalization of Chinese soybean purchases, but offers no hedge against the possibility that these tailwinds fade, leaving the core agribusiness exposed to cyclical downturns without sufficient structural improvement in profitability.
The Carbohydrate Solutions segment’s apparent strength, particularly in ethanol, is vulnerable to policy-dependent tailwinds that may not be durable and is being offset by persistent structural decline in starches and sweeteners—a business that management acknowledged is under secular pressure. While ethanol margins strengthened due to RVO clarity and 45Z expectations, the segment’s gains are being driven largely by external policy support rather than inherent operational superiority. Management conceded that starches and sweeteners volumes and margins continue to face pressure from similar trends seen in 2025, with only an 11% increase in operating profit in the subsegment despite broader segment growth of 48%. This indicates that the ethanol-driven upside is not translating into broad-based strength across the carbohydrate portfolio. More concerning is the lack of a clear, scalable path to offset the decline in traditional sweeteners and starches through biosolutions or industrial applications—efforts in areas like personal care or fabric softeners remain nascent and are explicitly described as smaller markets requiring more effort to develop. The company’s strategy of "fighting for the grind" through diversification has yet to demonstrate material revenue contribution at scale, leaving the segment exposed to continued erosion in its core food-facing businesses. If policy support for ethanol wavers or if industrial applications fail to scale, the Carbohydrate Solutions segment could quickly revert to low or negative growth, undermining the narrative of a broad-based recovery.
ADM’s nutrition business, while showing improved profitability, remains exposed to margin pressure from input costs, foreign exchange volatility, and the limited scalability of premium product lines, casting doubt on the sustainability of its recent outperformance. Human nutrition operating profit rose 39% year-over-year, but this was bolstered by foreign exchange gains and the recovery of the Decatur East plant—a facility whose return to full operations is described as ongoing, not yet complete, with management acknowledging they have not recovered their full prior market position. The reliance on facility recovery and FX gains introduces non-recurring elements into the performance beat, suggesting that core organic growth in human nutrition may be more modest than the headline numbers indicate. Furthermore, the company’s shift toward higher-margin product lines in animal nutrition, while beneficial, is constrained by the need to overcome customer inertia and the relatively small size of specialty markets compared to commodity feed. Management cited ongoing cost optimization and portfolio actions as drivers, but these are incremental and may not be sufficient to offset long-term pressure from private label competition and declining demand for traditional feed additives. The segment’s growth is also vulnerable to fluctuations in input costs such as dairy, cocoa, and specialty grains, which are not fully hedged and could compress margins if inflation persists. Without clear evidence of scalable, proprietary innovation beyond flavors and isolated enzyme projects, the nutrition segment’s current momentum may reflect a temporary cyclical bounce rather than a structural transformation.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Farm Products

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	ADM	Archer-Daniels-Midland Co	41.79 Bn	38.55	0.52	8.22 Bn
2	BG	Bunge Global SA	23.70 Bn	329.16	0.29	12.67 Bn
3	CALM	Cal-Maine Foods Inc	4.20 Bn	13.20	1.44	-
4	DMC	Del Monte Corp	1.35 Bn	18.61	0.32	0.46 Bn
5	DOLE	Dole plc	1.34 Bn	-29.05	0.14	0.91 Bn
6	AGRO	Adecoagro S.A.	1.10 Bn	24.33	0.77	1.52 Bn
7	VITL	Vital Farms, Inc.	0.57 Bn	7.92	0.72	-
8	ALCO	Alico, Inc.	0.30 Bn	-15.59	18.17	0.08 Bn

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password